Human Mass Balance Study of HMS5552 in Healthy Subjects

Completed · Phase 1

Conditions studied: Healthy Subject

In brief

This is an open-label, single center, 1-period study in healthy adult male subjects to assess absorption, metabolism, and excretion of HMS5552 after a single oral administration of 50 mg (90 μCi) of \[14C\]-HMS5552.

Key facts

Study ID

NCT03158506

Run by

Hua Medicine Limited

People needed

6

Starts

2017-03-29

Expected to finish

2017-04-06

Last updated by the study team

2018-12-31

Who can join

Age: 19 and older, up to 55. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Healthy, adult, male 19-55 years of age
• Weight at least 50 kg, and BMI within the range of 18-30 kg/m2
• Written informed consent must be obtained before any assessment is performed

You may not qualify if…

• History or presence of clinically significant medical, surgical or psychiatric condition or disease in the opinion of the Investigator or designee which might significantly alter the absorption, distribution, metabolism and excretion of drugs.
• History or presence of alcoholism or drug abuse.
• Smoker.
• Abnormal bowel habits.

Where it is running

• Celerion — Lincoln, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.